United Kingdom UK Approves Lilly’s Alzheimer’s Drug, But Concerns Over Cost Persist October 23, 2024 – The UK has approved Eli Lilly’s new Alzheimer’s treatment, donanemab, marking a significant milestone in the fight against… By Telegraph News · 23 October 2024